Table 1.
Preoperative baseline characteristics.
| Transvesical approach (n = 44) | Posteriorapproach (n = 52) | p | |
|---|---|---|---|
| Age, years, mean (SD) | 64.8 (6.5) | 67.4 (7.4) | 0.081 |
| BMI, kg/m2, mean (SD) | 26.3 (3.2) | 27.2 (3.6) | 0.208 |
| Diabetes mellitus (yes), n (%) | 7 (15.9%) | 7 (13.5%) | 0.735 |
| Hypertension (yes), n (%) | 18 (40.9%) | 23 (44.2%) | 0.743 |
| Preoperative serum total PSA, ng/mL, mean (SD) | 13.3 (3.7) | 15.2 (7.4) | 0.097 |
| Prostate volume, mL, mean (SD) | 35.5 (10.2) | 38.6 (9.3) | 0.125 |
| Prostate volume ≥ 50 and < 80 ml, n (%) | 3 (6.8%) | 5 (9.6%) | 0.723 |
| Preoperative IIEF-5 score, median (IQR) | 17 (14, 20) | 17 (14.25, 19) | 0.402 |
| cTNM stage, n (%) | 0.090 | ||
| cT1c | 6 (13.6%) | 12 (23.1%) | |
| cT2a | 29 (65.9%) | 27 (51.9%) | |
| cT2b | 9 (20.5%) | 8 (15.4%) | |
| cT2c | 0 (0%) | 5 (9.6%) | |
| Biopsy Gleason score, median (IQR) | 6 (5, 7) | 6 (5, 7) | 0.301 |
| Biopsy Gleason score = 7, n (%) | 14 (31.8%) | 24 (46.2%) | 0.152 |
BMI, body mass index; IIEF, International Index of Erectile Function; SD, standard deviation; IQR, interquartile range.